Seasoned private equity and corporate finance professional focused on growth-stage technology and healthcare investments. Jeffrey D Matchett-Robles brings experience in deal sourcing, due diligence, portfolio operations and capital markets strategy across cross-border transactions. Often works with founder-led teams to scale go-to-market, optimize financial operations and prepare companies for liquidity events. Active in board advisory roles and fundraising for mid-market buyouts and growth equity strategies.
Seasoned private equity and corporate finance professional focused on growth-stage technology and healthcare investments. Jeffrey D Matchett-Robles brings experience in deal sourcing, due diligence, portfolio operations and capital markets strategy across cross-border transactions. Often works with founder-led teams to scale go-to-market, optimize financial operations and prepare companies for liquidity events. Active in board advisory roles and fundraising for mid-market buyouts and growth equity strategies.
Focuses on growth-stage technology and healthcare companies where operational improvement and capital structure optimization unlock scale. Prefers founder-led opportunities with clear go‑to‑market expansion plans, applying rigorous due diligence, hands‑on portfolio operations and board-level governance to accelerate revenue and margin expansion. Capital allocation emphasizes growth equity and mid‑market buyouts with staged financing, milestone‑linked capital and exit planning toward strategic sales or IPOs. Risk discipline blends deep sector expertise, cross‑border deal execution and capital markets timing to balance upside from operational value creation with downside protection via covenants and active oversight.
Focuses on growth-stage technology and healthcare companies where operational improvement and capital structure optimization unlock scale. Prefers founder-led opportunities with clear go‑to‑market expansion plans, applying rigorous due diligence, hands‑on portfolio operations and board-level governance to accelerate revenue and margin expansion. Capital allocation emphasizes growth equity and mid‑market buyouts with staged financing, milestone‑linked capital and exit planning toward strategic sales or IPOs. Risk discipline blends deep sector expertise, cross‑border deal execution and capital markets timing to balance upside from operational value creation with downside protection via covenants and active oversight.
| Trades 284 | Longs Won 226/284 79% | Profit Factor 43.51 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $906,563.14 |
| Average Win $184,465.34 | Best Trade (Jul 15) $12.09M | Sharpe Ratio -11.41 |
| Average Loss -$16,520.22 | Worst Trade (Jul 10) -$395,154.02 | Z-Score 14.69 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 2w 1d | Expectancy $143,419 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.25% |
| Consecutive Losing Trades | 9,901 | 8,911 | 7,921 | 6,931 | 5,941 | 4,950 | 3,960 | 2,970 | 1,980 | 990 |